DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
Ausgabe 02 ·
Volume 56 ·
Februar 1996
DOI: 10.1055/s-002-9095
Originalarbeiten
63
Gitsch, G.:
Therapy of Early Stage Vulvar Cancer
70
Kurbacher, C. M.;
Mallmann, P.;
Kurbacher, J. A.;
Hübner, H.;
Krebs, D.:
Chemosensitivity Testing in Gynaecological Oncology
79
Nagele, F.;
Kurz, Chr.;
Speiser, P.;
Vavra, N.;
Sevelda, P.:
CA 125 as a Prognostic Factor for Survival in Patients with FIGO-Stage I Epithelial Ovarian Cancer - Preliminary Results
83
Radke, Jacqueline;
Schmidt, Doris;
Böhme, M.;
Schmidt, U.;
Weise, W.;
Morenz, J.:
Cytokine Levels in Malignant Ascites and Peripheral Blood of Patients with Advanced Ovarian Cancer
88
Lippert, T. H.;
Mück, A. O.:
Can Prophylactic Treatment of Preeclampsia be Performed with Low-Dose Aspirin? Critical Assessment of Available Studies
93
Niesert, St.:
Obstetric Prognosis after Preeclampsia, Eclampsia and HELLP Syndrome
97
Hecher, K.;
Reinhold, U.;
Gbur, K.;
Hackelöer, B.-J.:
Interruption of Umbilical Blood Flow in an Acardiac Twin by Endoscopic Laser Coagulation
105
Kuhn, W.;
Schmalfeldt, B.;
Dose, J.;
Pache, L.;
Ulm, K.;
Freitag, K.;
Jänicke, F.;
Graeff, H.:
Oral and Parenteral Etoposide in Platinum Refractory Ovarian Cancer Patients
Klinische Einzelbeobachtungen
101
Kaiser, C.;
Flachowsky, St.;
Riehn, A.;
Distler, W.:
Case Report on Clinical and Pathophysiological Similarities in Moschcowitz's Disease and HELLP Syndrome
